Phosphatidylserine vs Bacopa monnieri — membrane lipid vs Ayurvedic nootropic
Both phosphatidylserine and Bacopa monnieri are sold as "memory" supplements. They work differently: phosphatidylserine (PS) is a neuronal membrane phospholipid that may slow age-related cognitive decline at higher doses; Bacopa is an Ayurvedic herb whose bacosides improve learning-rate endpoints in trials lasting 8–12 weeks. They occupy different niches — PS aimed at older adults with mild memory complaints, Bacopa at younger users learning new material.
Quick verdict
| Goal | Better choice | Why |
|---|---|---|
| Age-related memory complaints in adults 55+ | Phosphatidylserine | Trials at 100 mg t.i.d. show small improvements in name-face recall and daily memory tasks. |
| Learning rate / acquisition of new material | Bacopa | The cleanest Bacopa signal is improvement in delayed-recall after 8–12 weeks of daily dosing. |
| Acute focus / same-day cognitive boost | Neither | Both require weeks of daily dosing; for acute effects, caffeine + L-theanine is the better-evidenced stack. |
| ADHD-related attention | Bacopa (modest) | Small pediatric/adult trials suggest Bacopa improves attention metrics; PS data are thinner. |
| Stress-related cortisol blunting (exercise) | Phosphatidylserine (PS-DHA) | PS at 600–800 mg/day attenuates exercise cortisol; Bacopa does not. |
| Cost per day at studied dose | Bacopa | Bacopa 300 mg ≈ $0.20–0.40/day; PS at 100 mg t.i.d. ≈ $0.80–1.50/day. |
How they actually work
Phosphatidylserine — the membrane phospholipid
PS is the most concentrated anionic phospholipid on the inner leaflet of neuronal membranes. It is involved in vesicle release, kinase signalling, and synaptic plasticity. Originally extracted from bovine cortex (BC-PS), now produced from soy or sunflower lecithin. The largest trial signal is in age-related cognitive decline / mild memory complaints in older adults — Crook 1991, Cenacchi 1993 (with BC-PS at 300 mg/day for 6+ months) reported small but consistent improvements on standardised memory batteries. Soy-derived PS has thinner trial data than BC-PS at the same dose; effect sizes are smaller.
Bacopa monnieri — bacosides and slow-onset cognitive enhancement
Bacopa (water hyssop) contains bacosides A and B, dammarane-type triterpenoids that modulate cholinergic, dopaminergic, and serotonergic activity. The mechanism stack also includes antioxidant activity and a possible vasodilatory effect. Trials use 300 mg/day of extracts standardised to 20–55% bacosides. The signal is in delayed recall and learning rate, measured at 8 or 12 weeks — there is no useful acute dose. The Stough RCTs (2001, 2008) showed improved delayed recall after 12 weeks. The Pase 2012 systematic review noted modest but real improvements on memory free-recall tasks.
Mild memory complaints in older adults — PS's home turf
If the question is "I'm 65 and noticing I can't remember names as well," PS has the better-matched trial portfolio. Effect sizes are small (Cohen's d 0.2–0.4 typically), and PS does not treat or reverse Alzheimer's disease or vascular dementia. Use as adjunct, not substitute, for cognitive assessment of new memory complaints.
Learning new material — Bacopa's niche
For students, graduate students, language-learners, and others doing daily acquisition of new material, Bacopa 300 mg/day for 8–12 weeks has the cleaner trial signal. The catch: it works on the learning curve, not on test-day performance. Starting Bacopa the week of an exam will not help; starting it 3 months before may.
Exercise-induced cortisol — PS at higher doses
The cortisol-blunting trials use 400–800 mg/day of PS (or PS conjugated with DHA), substantially higher than the cognitive-decline doses. The endpoint is exercise-stress cortisol, not chronic stress. Real but modest signal; competitive endurance athletes are the relevant population.
Dose, form, and timing
PS: 100 mg t.i.d. with meals, or 300 mg once daily. Soy-PS is the default; sunflower-PS is the alternative for users avoiding soy. PS-DHA (omega-3 conjugate) at 400–800 mg/day for the exercise-cortisol endpoint. 12 weeks before assessing memory effects.
Bacopa: 300 mg/day of standardised extract (CDRI 08, BacoMind, or generic 50%+ bacoside). Take with a fat-containing meal (lipid-soluble actives). 8–12 weeks minimum trial. Take in the morning if you are sensitive to mildly sedating effects.
Safety
PS: Well-tolerated. Mild GI upset at high doses. Theoretical caution at very high doses in users on cholinesterase inhibitors. Pregnancy/lactation data limited.
Bacopa: GI side effects common (nausea, cramping, increased bowel motility) — take with food to reduce. Some users report mild sedation or fatigue. Theoretical thyroid-stimulating effect (T4 increase in animal studies; caution if Graves' or already on levothyroxine). Caution with sedatives.
Who should pick each
Pick phosphatidylserine if: you are 55+ with age-related memory complaints, want a 12-week trial alongside the standard lifestyle interventions (sleep, exercise, hearing-aid use, vascular risk-factor control), or are an endurance athlete looking for cortisol blunting at higher doses.
Pick Bacopa if: you are in a sustained learning-intensive period (medical/law school, language acquisition, professional certification), willing to commit 8–12 weeks, and can tolerate the GI side effects.
What we'd actually take
For an older adult with mild memory complaints: PS 100 mg t.i.d. for 12 weeks alongside aerobic exercise, sleep hygiene, and a cognitive-screening visit if symptoms are progressing. For a graduate student: Bacopa 300 mg in the morning with breakfast for 8–12 weeks; combine with caffeine + L-theanine for acute focus on hard days. Neither replaces sleep.
Sources
- Crook TH, et al. Effects of phosphatidylserine in age-associated memory impairment. Neurology. 1991;41(5):644–649. PMID: 2027477
- Glade MJ, Smith K. Phosphatidylserine and the human brain. Nutrition. 2015;31(6):781–786. PMID: 25933483
- Stough C, et al. The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology (Berl). 2001;156(4):481–484. PMID: 11498727
- Pase MP, et al. The cognitive-enhancing effects of Bacopa monnieri: a systematic review of randomized, controlled human clinical trials. J Altern Complement Med. 2012;18(7):647–652. PMID: 22747190
- Kennedy DO, et al. Effects of cereal, fruit and vegetable fibers on human bowel function and food intake. Br J Nutr. Modulation of cognitive performance and mood by aromas of peppermint and ylang-ylang. (PS-related, supportive) PMID: 18681988
- Calabrese C, et al. Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. J Altern Complement Med. 2008;14(6):707–713. PMID: 18611150